Denali Therapeutics Inc. (DNLI) Price History & Returns
How Denali Therapeutics Inc. (DNLI) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $18.41 sits 34% of the way up a 52-week range of $13.75 to $27.30; 32.6% below the 52-week high; a beta of 1.00 means it has historically moved more than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
3 of 9 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 16 of 36 months closed higher than the month before. Each figure is the last close in that month.
Denali Therapeutics Inc. (DNLI) price history — frequently asked questions
How has Denali Therapeutics Inc. performed over the last year?
Denali Therapeutics Inc. (DNLI) has risen 53.4% over the last twelve months, measured on price alone.
What is Denali Therapeutics Inc.'s five-year return?
Over five years the DNLI share price has lost 53.5%, excluding dividends.
What is Denali Therapeutics Inc.'s 52-week range?
Over the last year Denali Therapeutics Inc. (DNLI) has traded between $13.75 and $27.30.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.